Jacobs Levy Equity Management
PYXS icon

Jacobs Levy Equity Management’s Pyxis Oncology PYXS Stock Holding History

Jacobs Levy Equity Management’s Portfolio PYXS Stock Details PYXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$673K Buy
+460,997
New +$695K ﹤0.01% 775
2025
Q4 		– Sell
-60,333
Closed -$134K – 1038
2025
Q3 		$134K Buy
+60,333
New +$86.9K ﹤0.01% 933
2025
Q1 		– Sell
-601,940
Closed -$939K – 1175
2024
Q4 		$939K Buy
601,940
+219,100
+57% +$632K ﹤0.01% 723
2024
Q3 		$1.41M Buy
+382,840
New +$1.34M 0.01% 668

Other funds holding PYXS

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
GGI
GordonMD Global Investments Beverely Hills, California $144M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
HP
HealthInvest Partners Stockholm, Sweden $310M AUM 37.86% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jacobs Levy Equity Management's PYXS Position: Q1 2026 in Review

Jacobs Levy Equity Management opened a new position in Pyxis Oncology (PYXS) in Q1 2026: 460,997 shares worth $673K. The stake represents ﹤0.01% of the portfolio and ranks #775 among its holdings. This is a return to the name: Jacobs Levy Equity Management previously reported a position in PYXS as recently as Q3 2025.

Jacobs Levy Equity Management first reported a position in PYXS in Q3 2024 and has held it in 4 quarters since. The position peaked at $1.41M in Q3 2024. 78 funds tracked by Wall St. Rank hold PYXS as of Q1 2026.

  • Jacobs Levy Equity Management held 460,997 shares of Pyxis Oncology worth $673K as of Q1 2026.
  • Pyxis Oncology was a new Jacobs Levy Equity Management position in Q1 2026.
  • Pyxis Oncology made up ﹤0.01% of Jacobs Levy Equity Management's portfolio in Q1 2026, its #775 holding.
  • Jacobs Levy Equity Management first reported a position in Pyxis Oncology in Q3 2024 and has held it in 4 quarters since.
  • Jacobs Levy Equity Management's Pyxis Oncology position peaked at $1.41M in Q3 2024.
  • 78 funds tracked by Wall St. Rank held Pyxis Oncology as of Q1 2026.

Based on Jacobs Levy Equity Management's 13F filing for Q1 2026, filed 15 May 2026.